Wide Ranks

BIOR

Biora Therapeutics, Inc.

1.93

Top Statistics
Market Cap 8 M Forward PE -0.1664 Revenue Growth 15800.00 %
Current Ratio 0.20 Trailing PE 5.36 Earnings Growth 0.00 %
Profit Margins 0.00 % Peg Ratio Dividend Yield 0.00 %
Enterprice / EBITA -0.7560 Enterprise / Revenue 59.36 Price To Sales Trailing12 Months 10.15
Profitability
Profit Margins 0.00 % Operating Margins -4964.15 %
Balance Sheet
Total Cash 5 M Total Cash Per Share 1.46 Total Debt 48 M
Total Debt To Equity Current Ratio 0.20 Book Value Per Share -36.43
All Measures
Short Ratio 294.00 % Message Board Id finmb_256359845 Shares Short Prior Month 212713
City San Diego Uuid c76a9347-144a-3b6a-82b2-fd6494eb6e41 Previous Close 1.79
First Trade Date Epoch Utc 1 B Book Value -36.43 Beta 1.28
Total Debt 48 M Volume 139395 Last Split Date 1 B
Fifty Two Week Low 1.43 Total Cash Per Share 1.46 Total Revenue 860000
Shares Short Previous Month Date 1 B Target Median Price 34.00 Max Age 86400
Recommendation Mean 2.00 Sand P52 Week Change 0.3133 Operating Margins -4964.15 %
Target Mean Price 34.00 Net Income To Common -86810000 Short Percent Of Float 0.0615
Implied Shares Outstanding 4 M Trailing Peg Ratio None Last Fiscal Year End 1 B
Average Daily Volume10 Day 134470 Average Volume10days 134470 Total Cash 5 M
Next Fiscal Year End 1 B Revenue Per Share 0.3290 Held Percent Insiders 0.0010
Trailing PE 5.36 Date Short Interest 1 B Most Recent Quarter 1 B
Regular Market Previous Close 1.79 Target Low Price 23.00 Gmt Off Set Milliseconds -18000000
Fifty Day Average 3.97 Open 1.81 Free Cashflow -19177876
State CA Dividend Yield 0.00 % Return On Assets -1.25
Time Zone Short Name EST Trailing Eps 0.3600 Day Low 1.79
Address1 4330 La Jolla Village Drive Shares Outstanding 4 M Price Hint 4
Target High Price 45.00 Website https://www.bioratherapeutics.com 52 Week Change -0.8444
Average Volume 71515 Forward Eps -11.60 Recommendation Key buy
Compensation As Of Epoch Date 1 B Quick Ratio 13.40 % Last Split Factor 1:10
Regular Market Day High 1.94 Is_sp_500 False Profit Margins 0.00 %
Fifty Two Week High 19.90 Day High 1.94 Shares Short 201804
Regular Market Open 1.81 Industry Key biotechnology Earnings Growth 0.00 %
Enterprise To Revenue 59.36 Revenue Growth 15800.00 % Shares Percent Shares Out 0.0456
Operating Cashflow -48227000 Currency USD Time Zone Full Name America/New_York
Market Cap 8 M Is_nasdaq_100 False Zip 92122
Quote Type EQUITY Industry Biotechnology Long Name Biora Therapeutics, Inc.
Regular Market Day Low 1.79 Held Percent Institutions 0.2939 Current Price 1.93
Address2 Suite 300 Enterprise To Ebitda -0.7560 Financial Currency USD
Current Ratio 0.20 Gross Margins 100.00 % Industry Disp Biotechnology
Number Of Analyst Opinions 2 Country United States Float Shares 2 M
Two Hundred Day Average 6.72 Enterprise Value 51 M Price To Sales Trailing12 Months 10.15
Forward PE -0.1664 Regular Market Volume 139395 Ebitda -67510000
Exchange NGM
Go to Yahoo Finance Go to Seeking Alpha 
Biora Therapeutics, Inc., a clinical-stage biotechnology company, engages in developing oral biotherapeutics in the United States.

The company offers NaviCap, a targeted oral delivery platform for delivery of therapeutics in the gastrointestinal tract to enhance the treatment of inflammatory bowel diseases; and BioJet, a systemic oral delivery platform designs to replace injection with needle-free, oral delivery of large molecules for management of chronic diseases.

The company was formerly known as Progenity, Inc. and changed its name to Biora Therapeutics, Inc. in April 2022 to reflect its focus on its therapeutics pipeline.

Biora Therapeutics, Inc. was founded in 2010 and is headquartered in San Diego, California.